Xaluprine 20mg/ml oral suspension
BNF presentation 0801030L0BCABAQ within chapter Malignant Disease and Immunosuppression. Analyse prescribing behaviour, spending pressure, and high-usage pharmacies.
Product
Chemical substance
Presentation code
0801030L0BCABAQ
Usage overview
Total items and spend derived from NHS dispensing data.
Items dispensed
10
NHS spend (£)
£1,712.67
Recent activity
March 2025
Monitor this presentation to understand cost pressures, availability challenges, and opportunities for clinical optimisation.
Dispensing trend
Month-by-month national usage.
| Month | Items dispensed |
|---|---|
| March 2025 | 1 |
| December 2024 | 2 |
| November 2024 | 3 |
| June 2021 | 1 |
| December 2020 | 3 |
Top pharmacies dispensing this medicine
Identify providers with the highest utilisation to focus engagement and support.
| Pharmacy | Items | Region |
|---|---|---|
| Unknown pharmacy | 2 | No data available |
| Unknown pharmacy | 2 | No data available |
| Unknown pharmacy | 2 | No data available |
|
Kimbolton Medical Centre
ODS D81038
|
1 | 06H - CAMBRIDGESHIRE & PETERBOROUGH ICB |
|
Creffield Medical Group
ODS F81115
|
1 | 06T - SUFFOLK AND NORTH EAST ESSEX ICB |
| Unknown pharmacy | 1 | No data available |
|
Abbeywell Surgery
ODS J82145
|
1 | D9Y0V - HAMPSHIRE AND ISLE OF WIGHT ICB |